Conjunctivitis, Bacterial: Clinical Trials

4 trials for Conjunctivitis, Bacterial, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4

Follow Conjunctivitis, Bacterial: new trials by email Literature Review of Conjunctivitis, Bacterial trials Research Report on Conjunctivitis, Bacterial

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects
PRO-231, VIGAMOXI® - Ophthalmological Agent Toxicity, Bacterial Conjunctivitis
Phase 1CompletedLaboratorios Sophia S.A de C.V.372024-01-302025-06-15
Safety and Immunogenicity of a Chlamydia Vaccine CTH522
CTH522-CAF01 IM, CTH522-CAF09b IM, CTH522 ID - Trachoma
Phase 1CompletedStatens Serum Institut652020-02-172024-08-22
Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects
PRO-174, Sophixín Ofteno® - Conjunctivitis, Conjunctivitis, Bacterial
Phase 1CompletedLaboratorios Sophia S.A de C.V.302018-01-252019-10-25
Systemic Pharmacokinetics of BOL-303224-A
BOL-303224-A - Conjunctivitis, Bacterial
Phase 1CompletedBausch & Lomb Incorporated242006-10-012011-12-09

Narrower conditions

Chlamydia Infections (1)  ·  Conjunctivitis (1)  ·  Trachoma (1)

Broader conditions

Bacterial Infections (4)  ·  Bacterial Infections and Mycoses (4)  ·  Conjunctival Diseases (4)  ·  Eye Diseases (4)  ·  Eye Infections (4)  ·  Eye Infections, Bacterial (4)  ·  Infections (4)  ·  Conjunctivitis (3)  ·  Chlamydiaceae Infections (1)  ·  Communicable Diseases (1)  ·  Corneal Diseases (1)  ·  Genital Diseases (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Sexually Transmitted Diseases (1)

Interventions

Moxifloxacin (1)  ·  Sodium Chloride (1)  ·  besifloxacin (1)

Sponsors

Laboratorios Sophia S.A de C.V. (2)  ·  Bausch & Lomb Incorporated (1)  ·  Statens Serum Institut (1)

Countries

Mexico (2)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Alejandra Sanchez-Rios, MD (1)  ·  Alvaro Borges, MD (1)  ·  Katrina Pollock, MD (1)  ·  Lina S Stoey, MPH (1)  ·  Pernille N Tingskov, BS (1)  ·  Rebecca B Dohn, Pharm (1)

Results publications

PMID 34707360, PMID 38615673